ACTA2 and breast carcinoma: Peng et al. [20] experimentally demonstrated that ACTA2-AS1 serves as a tumor suppressor and dramatically inhibits tumor cell proliferation, invasion ability, and progression of MDA-MB-231 breast cancer cells.